Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T21:51:05.127Z.
Calculation as of: 2026-10-06T21:51:05.127Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3557795f844472894604fcbd35c20595803ff4fe2165ab850e9e673e91650e7f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
BeyondSpring Inc.
Market Cap
$28.47M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| BeyondSpring Inc. (BYSI) | $28.47M | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.31M | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
